Christopher B. Driscoll

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Oncolytic virus-derived type I interferon restricts CAR T cell therapy”.

Oncolytic virus-derived type I interferon restricts CAR T cell therapy

Nature Communications(2020)10.1038/s41467-020-17011-z

N/A

0DataRank · unranked

120 citations

Amanda L. Huff, Phonphimon Wongthida, Jill Thompson, Tim Kottke, Jason M. Tonne +15 more

APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy

Nature Communications(2020)10.1038/s41467-020-14568-7

N/A

0DataRank · unranked

78 citations

Matthew Schuelke, Timothy Kottke, Jill Thompson, Phonphimon Wongthida, Jason M. Tonne +15 more

Ad-CD40L mobilizes CD4 T cells for the treatment of brainstem tumors

Neuro-Oncology(2020)10.1093/neuonc/noaa126

N/A

0DataRank · unranked

16 citations

Matthew Schuelke, Christopher B. Driscoll, Timothy Kottke, Jill Thompson, Jason M. Tonne +8 more

Vesicular Stomatitis Virus Encoding a Destabilized Tumor Antigen Improves Activation of Anti-tumor T Cell Responses

Molecular Therapy(2020)10.1016/j.ymthe.2020.08.013

N/A

0DataRank · unranked

7 citations

Laura Evgin, Jill Thompson, Tim Kottke, Christopher B. Driscoll, Jason M. Tonne +7 more

Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy

Nature Communications(2021)10.1038/s41467-021-22115-1

N/A

0DataRank · unranked

28 citations

Jason M. Tonne, Laura Evgin, Christopher B. Driscoll, Jacob P. van Vloten, Victoria A. Jennings +17 more

miRNA-mediated control of exogenous OCT4 during mesenchymal-epithelial transition increases measles vector reprogramming efficiency

Molecular Therapy — Methods & Clinical Development(2021)10.1016/j.omtm.2021.11.012

N/A

0DataRank · unranked

9 citations

Brenna Sharp, Carolina Colli Cruz, Qi Wang, Alexis Locsin, Christopher B. Driscoll +4 more